Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.

Guo HQ, Zhao H, Zhang ZH, Zhu YL, Xiao T, Pan QJ.

Dis Markers. 2014;2014:912182. doi: 10.1155/2014/912182. Epub 2014 Jan 29.

2.

Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.

Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.

Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005. Epub 2014 Aug 8.

PMID:
25111330
3.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
4.

Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.

Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.

Cytopathology. 2014 Jun;25(3):146-54. doi: 10.1111/cyt.12125. Epub 2014 Jan 12.

PMID:
24417615
5.

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.

Thyroid. 2009 Aug;19(8):837-42. doi: 10.1089/thy.2009.0074.

PMID:
19534623
6.

BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.

Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.

Acta Cytol. 2011;55(6):570-5. doi: 10.1159/000333274. Epub 2011 Dec 9.

PMID:
22156468
7.

Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".

Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.

Head Neck. 2015 Dec;37(12):1788-93. doi: 10.1002/hed.23829. Epub 2014 Sep 25.

PMID:
24989827
8.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.

PMID:
22181337
9.

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.

Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M.

Cancer Cytopathol. 2015 Jun;123(6):356-61. doi: 10.1002/cncy.21546. Epub 2015 Apr 29.

10.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.

11.

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

PMID:
22500044
12.

Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.

Lee SR, Jung CK, Kim TE, Bae JS, Jung SL, Choi YJ, Kang CS.

Thyroid. 2013 Nov;23(11):1416-22. doi: 10.1089/thy.2012.0640. Epub 2013 Jul 25.

13.

RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.

An JH, Song KH, Kim SK, Park KS, Yoo YB, Yang JH, Hwang TS, Kim DL.

Clin Endocrinol (Oxf). 2015 May;82(5):760-6. doi: 10.1111/cen.12579. Epub 2014 Nov 28.

PMID:
25109485
14.

Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.

Beaudenon-Huibregtse S, Alexander EK, Guttler RB, Hershman JM, Babu V, Blevins TC, Moore P, Andruss B, Labourier E.

Thyroid. 2014 Oct;24(10):1479-87. doi: 10.1089/thy.2013.0640. Epub 2014 Jun 18.

PMID:
24811481
15.

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.

Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.

World J Surg. 2010 Nov;34(11):2595-603. doi: 10.1007/s00268-010-0729-4.

PMID:
20652698
16.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
17.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021. Epub 2011 May 13.

PMID:
21568726
18.

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.

Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.

J Clin Endocrinol Metab. 2012 Jul;97(7):2354-61. doi: 10.1210/jc.2011-3494. Epub 2012 Apr 24.

PMID:
22535974
19.

The molecular diagnosis and management of thyroid neoplasms.

Theoharis C, Roman S, Sosa JA.

Curr Opin Oncol. 2012 Jan;24(1):35-41. doi: 10.1097/CCO.0b013e32834dcfca. Review.

PMID:
22123232
20.

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F.

J Clin Endocrinol Metab. 2010 Mar;95(3):1365-9. doi: 10.1210/jc.2009-2103. Epub 2010 Feb 3.

PMID:
20130073

Supplemental Content

Support Center